The COVID-19 pandemic has presented new challenges to healthcare infrastructure, virology, vaccinology research, and implementation science. Misinformation concerning vaccines and non-pharmacologic measures to mitigate the spread of COVID-19 has made the study of vaccine efficacy extremely important for both transparency and accountability. The vaccines for COVID-19 were developed with urgency but without compromise of any safety or regulatory measures. They are undoubtedly the most efficacious means of disease mitigation we currently have available. As of this writing, 11.7 billion doses have been given worldwide, with 578 million in the USA alone.1
Unfortunately, due to the nature of the coronavirus, new variants continue to emerge. When dealing with a rapidly changing pathogen, it is essential to continuously review and update the known data, as manuscripts become outdated as soon as the first draft is written. In this issue of Journal of Investigative Medicine, Hirsh et al 2 …
Log in using your username and password
Log in through your institution
PURCHASE SHORT TERM ACCESS
Pay Per Article - You may access this article (from the computer you are currently using) for 1 day for US$37.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
